Vanguard amends Schedule 13G/A, reports 0 shares in Evolv (NASDAQ: EVLV)
Vanguard has filed an amended Schedule 13G/A for Evolv Technologies Holdings Inc. (NASDAQ: EVLV), reporting 0 shares beneficially owned and 0% ownership as of March 13, 2026. This amendment follows an internal realignment on January 12, 2026, which enables certain Vanguard subsidiaries to report their beneficial ownership separately in reliance on an SEC release. The filing clarifies that The Vanguard Group no longer claims beneficial ownership for securities held by these reallocated subsidiaries.
How this was made
The 30-second read
Why it matters
The change in beneficial ownership reporting is unlikely to influence Evolv's stock price or investor sentiment significantly.
Market read
The news has minimal relevance to trading decisions or market movements.
What to watch
Potential undisclosed reasons for the ownership change, such as internal rebalancing or regulatory considerations, are not publicly detailed.
Background
Vanguard's ownership filings are routine disclosures that reflect internal organizational changes rather than market-moving events.
Ticker impact
The news pertains to Vanguard's amended Schedule 13G/A for Evolv Technologies Holdings Inc., indicating a change in beneficial ownership reporting. This is a factual update but does not directly impact Evolv's stock fundamentals or trading activity.
Minimal to no immediate price movement expected
Ownership reporting changes are administrative and do not signal market sentiment shifts or fundamental changes in Evolv.
Market effects
Limited impact on the technology or biotech sectors; no sector-wide implications identified.
No regional market effects anticipated.
Negligible influence on global markets.
Counterpoint
Some traders might interpret the removal of Vanguard's beneficial ownership as a sign of strategic repositioning, potentially signaling future activity; however, evidence is lacking.
Key entities
- Institutional InvestorVanguard
A major global investment management company.
- Public CompanyEvolv Technologies Holdings Inc.
A company listed on NASDAQ involved in technology or biotech sectors.





